Foxp3+ regulatory T cells in mouse models of type 1 diabetes

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Petzold, Cathleen ^a   Riewaldt, Julia ^a   Watts, Deepika ^a   Sparwasser, Tim ^b   Schallenberg, Sonja ^a   Kretschmer, Karsten ^a,c  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL MODEL; ANTIGEN EXPRESSION; AUTOIMMUNITY; CELL ACTIVITY; CELL TRANSFER; IMMUNOCOMPETENCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 84879356078     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/940710     Document Type: Review

References (74)

1. McDevitt H. O., Unanue E. R., Autoimmune diabetes mellitus-much progress, but many challenges. Advances in Immunology 2008 100 1 12 2-s2.0-57749187239 10.1016/S0065-2776(08)00801-8
2. Anderson M. S., Bluestone J. A., The NOD mouse: a model of immune dysregulation. Annual Review of Immunology 2005 23 447 485 2-s2.0-17644361955 10.1146/annurev.immunol.23.021704.115643 (Pubitemid 40563177)
3. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunological Reviews 2006 212 8 27 2-s2.0-33746342994 10.1111/j.0105-2896.2006.00427.x (Pubitemid 44116697)
4. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009 (Pubitemid 351707693)
5. Wing K., Sakaguchi S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunology 2010 11 1 7 13 2-s2.0-74049164847 10.1038/ni.1818
6. Kassiotis G., Liston A., Sakaguchi S., Regulatory T cells: history and perspective. Regulatory T Cells 2011 Humana Press 3 17
7. Fife B. T., Guleria I., Bupp M. G., Eagar T. N., Tang Q., Bour-Jordan H., Yagita H., Azuma M., Sayegh M. H., Bluestone J. A., Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. Journal of Experimental Medicine 2006 203 12 2737 2747 2-s2.0-33751552197 10.1084/jem.20061577 (Pubitemid 44833349)
8. Van Belle T. L., Taylor P., von Herrath M. G., Mouse models for type 1 diabetes. Drug Discovery Today 2009 6 2 41 45 2-s2.0-77949487898 10.1016/j.ddmod.2009.03.008
9. Sarukhan A., Lanoue A., Franzke A., Brousse N., Buer J., Von Boehmer H., Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. The EMBO Journal 1998 17 1 71 80 2-s2.0-0032472406 10.1093/emboj/17.1.71 (Pubitemid 28041049)
10. Apostolou I., Hao Z., Rajewsky K., Von Boehmer H., Effective destruction of Fas-deficient insulin-producing β cells in type 1 diabetes. Journal of Experimental Medicine 2003 198 7 1103 1106 2-s2.0-0141993915 10.1084/jem.20030698 (Pubitemid 37248625)
11. + T cell-mediated spontaneous diabetes in noenatal mice. The Journal of Immunology 1996 157 3 978 983 2-s2.0-0030210309
12. + T cells. European Journal of Immunology 1992 22 4 1013 1022 2-s2.0-0026571924
13. Apostolou I., Von Boehmer H., The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations. Journal of Autoimmunity 2004 22 2 111 114 2-s2.0-1342302114 10.1016/j.jaut.2003.10.005 (Pubitemid 38258326)
14. Sarukhan A., Garcia C., Lanoue A., Von Boehmer H., Allelic inclusion of T cell receptor α genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 1998 8 5 563 570 2-s2.0-0032076047 10.1016/S1074-7613(00)80561-0 (Pubitemid 28264747)
15. Bruder D., Westendorf A. M., Hansen W., Prettin S., Gruber A. D., Qian Y., Von Boehmer H., Mahnke K., Buer J., On the edge of autoimmunity: Tcell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005 54 12 3395 3401 2-s2.0-33644691658 10.2337/diabetes.54.12.3395 (Pubitemid 43334328)
16. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M. C., von Boehmer H., Inducing and expanding regulatory T cell populations by foreign antigen. Nature Immunology 2005 6 12 1219 1227 2-s2.0-29244435493 10.1038/ni1265 (Pubitemid 43045633)
17. Kretschmer K., Heng T. S. P., von Boehmer H., De novo production of antigen-specific suppressor cells in vivo. Nature Protocols 2006 1 2 653 661 2-s2.0-34548751712 10.1038/nprot.2006.105
18. Sarukhan A., Lechner O., von Boehmer H., Autoimmune insulitis and diabetes in the absence of antigen-specific contact between T cells and β -islet cells. European Journal of Immunology 1999 29 10 3410 3416 (Pubitemid 29484232)
19. Vizler C., Bercovici N., Heurtier A., Pardigon N., Goude K., Bailly K., Combadiere C., Liblau R. S., Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. The Journal of Immunology 2000 165 11 6314 6321 2-s2.0-0034544505
20. Jaeckel E., Von Boehmer H., Manns M. P., Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005 54 2 306 310 2-s2.0-12744262844 10.2337/diabetes.54.2.306
21. + T cells into regulatory T cells and promotes immunotolerance in NOD mice. The Review of Diabetic Studies 2010 7 1 47 61 2-s2.0-79952116856
22. Klein L., Khazaie K., Von Boehmer H., In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proceedings of the National Academy of Sciences of the United States of America 2003 100 15 8886 8891 2-s2.0-0041806547 10.1073/pnas.1533365100 (Pubitemid 36899193)
23. - regulatory T cells. The Journal of Immunology 2007 179 12 8059 8068 2-s2.0-40049101909
24. Katz J. D., Wang B., Haskins K., Benoist C., Mathis D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993 74 6 1089 1100 2-s2.0-0027378612 10.1016/0092-8674(93)90730-E (Pubitemid 23289465)
25. Haskins K., Portas M., Bradley B., Wegmann D., Lafferty K., T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 1988 37 10 1444 1448 2-s2.0-0024226752 (Pubitemid 19035999)
26. Judkowski V., Pinilla C., Schroder K., Tucker L., Sarvetnick N., Wilson D. B., Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. The Journal of Immunology 2001 166 2 908 917 2-s2.0-0035863724 (Pubitemid 32060245)
27. Stadinski B. D., Delong T., Reisdorph N., Reisdorph R., Powell R. L., Armstrong M., Piganelli J. D., Barbour G., Bradley B., Crawford F., Marrack P., Mahata S. K., Kappler J. W., Haskins K., Chromogranin A is an autoantigen in type 1 diabetes. Nature Immunology 2010 11 3 225 231 2-s2.0-76949098835 10.1038/ni.1844
28. Feuerer M., Shen Y., Littman D. R., Benoist C., Mathis D., How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009 31 4 654 664 2-s2.0-70349755645 10.1016/j.immuni.2009.08.023
29. + regulatory T cells by peripheral expansion. The Journal of Immunology 2004 173 12 7259 7268 2-s2.0-10344220512 (Pubitemid 39628162)
30. Haribhai D., Lin W., Edwards B., Ziegelbauer J., Salzman N. H., Carlson M. R., Li S. H., Simpson P. M., Chatila T. A., Williams C. B., A central role for induced regulatory T cells in tolerance induction in experimental colitis. The Journal of Immunology 2009 182 6 3461 3468 2-s2.0-65449136307 10.4049/jimmunol.0802535
31. Knoechel B., Lohr J., Kahn E., Bluestone J. A., Abbas A. K., Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. Journal of Experimental Medicine 2005 202 10 1375 1386 2-s2.0-27944455288 10.1084/jem.20050855 (Pubitemid 41668740)
32. Katz J. D., Benoist C., Mathis D., T helper cell subsets in insulin-dependent diabetes. Science 1995 268 5214 1185 1188 2-s2.0-0029030964
33. Martin-Orozco N., Chung Y., Chang S. H., Wang Y. H., Dong C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. European Journal of Immunology 2009 39 1 216 224 2-s2.0-60549086638 10.1002/eji.200838475
34. Bettini M. L., Pan F., Bettini M., Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 2012 36 5 717 730
35. Darce J., Rudra D., Li L., An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 2012 36 5 731 741
36. + regulatory T cells induces a scurfy-like disease. Journal of Experimental Medicine 2007 204 1 57 63 2-s2.0-33846423147 10.1084/jem.20061852 (Pubitemid 46148756)
37. Zhou X., Jeker L. T., Fife B. T., Zhu S., Anderson M. S., McManus M. T., Bluestone J. A., Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. Journal of Experimental Medicine 2008 205 9 1983 1991 2-s2.0-51049120236 10.1084/jem.20080707
38. + regulatory T cells restore normoglycemia in diabetic NOD mice. Journal of Experimental Medicine 2007 204 1 191 201 2-s2.0-33846410255 10.1084/jem.20061631 (Pubitemid 46148769)
39. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. Journal of Experimental Medicine 2004 199 11 1467 1477 2-s2.0-2942692039 10.1084/jem.20040180 (Pubitemid 38780402)
40. + regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 8 2821 2826 2-s2.0-33847301982 10.1073/pnas.0611646104 (Pubitemid 46327963)
41. Hutchings P. R., Cooke A., The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. Journal of Autoimmunity 1990 3 2 175 185 2-s2.0-0025115596 10.1016/0896-8411(90)90139-J (Pubitemid 20344391)
42. Miller B. J., Appel M. C., O'Neil J. J., Wicker L. S., Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. The Journal of Immunology 1988 140 1 52 58 2-s2.0-0023905731 (Pubitemid 18050680)
43. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993 42 1 44 55 2-s2.0-0027468997 (Pubitemid 23013794)
44. + T cells and can be reversed by non-depleting antibodies targeting both T cell populations. Review of Diabetic Studies 2009 6 2 97 103 2-s2.0-70349690461 10.1900/RDS.2009.6.97
45. + regulatory T cells in systemic autoimmune diseases. Autoimmunity Reviews 2011 10 12 744 755
46. Moraes-Vasconcelos D., Costa-Carvalho B. T., Torgerson T. R., Ochs H. D., Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. Journal of Clinical Immunology 2008 28 1 S11 S19 2-s2.0-44449110577 10.1007/s10875-008-9176-5
47. Torgerson T. R., Ochs H. D., Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. The Journal of Allergy and Clinical Immunology 2007 120 4 744 750 2-s2.0-34948875308 10.1016/j.jaci.2007.08.044 (Pubitemid 47531861)
48. Wildin R. S., Smyk-Pearson S., Filipovich A. H., Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. Journal of Medical Genetics 2002 39 8 537 545 2-s2.0-0036346861 (Pubitemid 34864555)
49. Chatila T. A., Blaeser F., Ho N., Lederman H. M., Voulgaropoulos C., Helms C., Bowcock A. M., JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. The Journal of Clinical Investigation 2000 106 12 R75 R81 2-s2.0-0034526617 (Pubitemid 32038594)
50. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F., Ochs H. D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 2001 27 1 20 21 2-s2.0-0035167967 10.1038/83713 (Pubitemid 32044513)
51. Wildin R. S., Ramsdell F., Peake J., Faravelli F., Casanova J. L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Dagna Bricarelli F., Byrne G., McEuen M., Proll S., Appleby M., Brunkow M. E., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 2001 27 1 18 20 2-s2.0-0035163909 10.1038/83707 (Pubitemid 32044512)
52. Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., Wilkinson J. E., Galas D., Ziegler S. F., Ramsdell F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001 27 1 68 73 2-s2.0-0035162560 10.1038/83784 (Pubitemid 32044521)
53. + regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
54. + T reg cells impinge on autoimmune diabetes. Journal of Experimental Medicine 2005 202 10 1387 1397 2-s2.0-27944454429 10.1084/jem.20051409 (Pubitemid 41668741)
55. Riewaldt J., Dueber S., Boernert M., Severe developmental B lymphopoietic defects in Foxp3-deficient mice are refractory to adoptive regulatory T cell therapy. Frontiers in Immunology 2012 3, article 141 10.3389/fimmu.2012.00141
56. + T regulatory cells. The Journal of Immunology 2006 176 6 3301 3305 2-s2.0-33644841622 (Pubitemid 43363974)
57. + T regulatory cells'. The Journal of Immunology 2006 177 4, article 2036 2-s2.0-33746918744
58. + T regulatory cells'. The Journal of Immunology 2006 177 4 2036 2037 2-s2.0-33746879581 (Pubitemid 44200956)
59. + regulatory T cells in the islets in non-obese diabetic mice. Biochemical and Biophysical Research Communications 2008 367 4 719 724 2-s2.0-38649120073 10.1016/j.bbrc.2007.12.191
60. + regulatory T cells. Immunology 2007 121 1 15 28 2-s2.0-34047210905 10.1111/j.1365-2567.2007.02546.x (Pubitemid 46537670)
61. + T-cells control autoimmunity in the absence of B-cells. Diabetes 2009 58 7 1568 1577 2-s2.0-67650272801 10.2337/db08-1504
62. + regulatory T cells. The Journal of Immunology 2006 177 6 3695 3704 2-s2.0-33748500822 (Pubitemid 44359901)
63. Billiard F., Lobry C., Darrasse-Jeze G., Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. The Journal of Experimental Medicine 2012 209 5 1011 1028
64. Luo X., Pothoven K. L., McCarthy D., DeGutes M., Martin A., Getts D. R., Xia G., He J., Zhang X., Kaufman D. B., Miller S. D., ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14527 14532 2-s2.0-55749114418 10.1073/pnas.0805204105
65. Huebner M. P., Shi Y., Torrero M. N., Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF- β The Journal of Immunology 2012 188 2 559 568
66. Liu Q., Sundar K., Mishra P. K., Mousavi G., Liu Z., Gaydo A., Alem F., Lagunoff D., Bleich D., Gause W. C., Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infection and Immunity 2009 77 12 5347 5358 2-s2.0-72449121826 10.1128/IAI.01170-08
67. + regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. The Journal of Immunology 2006 176 7 4125 4132 2-s2.0-33646057433 (Pubitemid 44264391)
68. Fecci P. E., Sweeney A. E., Grossi P. M., Nair S. K., Learn C. A., Mitchell D. A., Cui X., Cummings T. J., Bigner D. D., Gilboa E., Sampson J. H., Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clinical Cancer Research 2006 12 14 4294 4305 2-s2.0-33845885624 10.1158/1078-0432.CCR-06-0053
69. Kim J. M., Rasmussen J. P., Rudensky A. Y., Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology 2007 8 2 191 197 2-s2.0-33846485153 10.1038/ni1428 (Pubitemid 46152650)
70. + regulatory T cells. PLoS ONE 7 8 e41971
71. + induced regulatory T cells using DEREG mice. PLoS ONE 2012 7 9 e44760
72. + Tregs using the DEREG mouse model. Methods in Molecular Biology 2011 707 157 172 2-s2.0-79955700323 10.1007/978-1-61737-979-6-10
73. + cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. The Journal of Immunology 2009 183 12 7631 7634 2-s2.0-76249088097 10.4049/jimmunol.0804308
74. + regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2004 101 supplement 2 14580 14585 2-s2.0-5144228520 10.1073/pnas.0404870101 (Pubitemid 39346727)